Suven Life Sciences Ltd.

Suven Life Sciences Ltd.

SUVEN

Suven Life Sciences Ltd.

Suven Life Sciences Ltd.

SUVEN

Suven Life Sciences Ltd. Share Price

364.95 -3.15 (-0.86%)
Suven Life Sciences is a clinical-stage biopharmaceutical Group focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. The goal is to be the leading biopharmaceutical Group focused on the treatment of dementia, a condition characterised by a significant decline in mental capacity and impaired daily function.
361.50Today's Low
368.30Today's High
124.1152W Low
393.5052W High

Fundamentals

Market Cap

₹10,401Cr

EPS

-₹12.13

Book Value/Share

₹16.48

Industry P/E (TTM)

51.77

P/B Ratio

16.41

Long Term D/E

0.02

ROE

-78.79%

Dividend Yield (TTM)

0.00%

Sector P/E Ratio (TTM)

41.98

Sector P/B Ratio

5.79

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Poor Quality

High Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Suven Life Sciences Ltd.

The share price of Suven Life Sciences Ltd. is ₹364.95 on NSE as of 28/8/2026, 5:47:11 pm. Share prices may change frequently due to market movements.

The market capitalisation of Suven Life Sciences Ltd. is ₹10,401Cr as of 28/8/2026, 5:47:11 pm

The current Price to Earnings (P/E) ratio of Suven Life Sciences Ltd. is 0.00 as of 28/8/2026, 5:47:11 pm

The Price to Book (P/B) ratio of Suven Life Sciences Ltd. stands at 16.41 as of 28/8/2026, 5:47:11 pm

Suven Life Sciences Ltd. reported an ROE of -78.80% for the last reported financial year on a consolidated account basis.

As of 28/8/2026, 5:47:11 pm, Suven Life Sciences Ltd.’s shareholding pattern is: promoters hold 70.10%, FIIs hold 0.60%, DIIs hold 2.90%, and public shareholders hold 26.40%.

The 52-week high of Suven Life Sciences Ltd. is ₹368.30 and the 52-week low is ₹361.50 as of 28/8/2026, 5:47:11 pm.

The earnings per share (EPS) of Suven Life Sciences Ltd. is ₹4.84 for the quarter ended Jun 2026.

The stock symbol of Suven Life Sciences Ltd. is SUVEN.

You can buy Suven Life Sciences Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Suven Life Sciences Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue3.57+134.87%
Other Income7.52+10.91%
Total Income11.09+33.61%
Total Expenditure136.07+160.92%
EBIDT-124.98+184.95%
Depreciation2.16+36.71%
Interest0.48+200.00%
Tax0.00-
Net Profit-127.61+179.85%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets546.71
Total Non-Current Assets77.51
Fixed assets76.59
Total Assets624.21
Total Current liabilities18.75
Total Non Current Liabilities14.06
Total Equity Plus Liabilities624.21
Total Shareholder Funds591.40
Total Debt to Equity0.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity-301.41
Cash from Financing Activities756.78
Cash from Investing Activities-462.11
Net Cash Flow-6.75

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages15

Bearish Moving Averages1

5 Day

368.60

10 Day

356.50

20 Day

339.10

30 Day

331.90

50 Day

321.00

100 Day

275.90

150 Day

231.60

200 Day

216.40

Indicators

RSI (14)

61.41

MACD (12, 26)

14.78

MACD Signal Line (9)

11.89

MFI (14)

84.54

ATR (14)

20.26

ADX (14)

29.44

ROC (21)

17.47

ROC (125)

143.86

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic373.63379.17384.23368.57363.03357.97352.43

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Suven Life Sciences is a clinical-stage biopharmaceutical Group focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. The goal is to be the leading biopharmaceutical Group focused on the treatment of dementia, a condition characterised by a significant decline in mental capacity and impaired daily function.
361.50Today's Low
368.30Today's High
124.1152W Low
393.5052W High

Fundamentals

Market Cap

₹10,401Cr

EPS

-₹12.13

Book Value/Share

₹16.48

Industry P/E (TTM)

51.77

P/B Ratio

16.41

Long Term D/E

0.02

ROE

-78.79%

Dividend Yield (TTM)

0.00%

Sector P/E Ratio (TTM)

41.98

Sector P/B Ratio

5.79

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Poor Quality

High Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Suven Life Sciences Ltd.

The share price of Suven Life Sciences Ltd. is ₹364.95 on NSE as of 28/8/2026, 5:47:11 pm. Share prices may change frequently due to market movements.

The market capitalisation of Suven Life Sciences Ltd. is ₹10,401Cr as of 28/8/2026, 5:47:11 pm

The current Price to Earnings (P/E) ratio of Suven Life Sciences Ltd. is 0.00 as of 28/8/2026, 5:47:11 pm

The Price to Book (P/B) ratio of Suven Life Sciences Ltd. stands at 16.41 as of 28/8/2026, 5:47:11 pm

Suven Life Sciences Ltd. reported an ROE of -78.80% for the last reported financial year on a consolidated account basis.

As of 28/8/2026, 5:47:11 pm, Suven Life Sciences Ltd.’s shareholding pattern is: promoters hold 70.10%, FIIs hold 0.60%, DIIs hold 2.90%, and public shareholders hold 26.40%.

The 52-week high of Suven Life Sciences Ltd. is ₹368.30 and the 52-week low is ₹361.50 as of 28/8/2026, 5:47:11 pm.

The earnings per share (EPS) of Suven Life Sciences Ltd. is ₹4.84 for the quarter ended Jun 2026.

The stock symbol of Suven Life Sciences Ltd. is SUVEN.

You can buy Suven Life Sciences Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Suven Life Sciences Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Suven Life Sciences Ltd.

Suven Life Sciences Ltd.

SUVEN

Open Price

368.00

Prev Close

368.10

Upper Circuit

441.70

Lower Circuit

294.50

Volume

2,11,420

Average Traded Price

364.07
361.50Today's Low
368.30Today's High
124.1152W Low
393.5052W High

Historical Performance

1 DayNA
5 DaysNA
1 MonthNA
3 MonthsNA
1 YearNA
5 YearsNA
10 YearsNA
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.